These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 34042149)
1. Highly selective C3-H iodination of pyrrolo[1,2- Liu Y; Wei Y; Yang Z; Li Y; Liu Y; Liu P Org Biomol Chem; 2021 Jun; 19(23):5191-5196. PubMed ID: 34042149 [TBL] [Abstract][Full Text] [Related]
2. Pd-Catalyzed direct C-H arylation of pyrrolo[1,2- Hao D; Yang Z; Liu Y; Li Y; Li C; Gu Y; Vaccaro L; Liu J; Liu P Org Biomol Chem; 2022 Jan; 20(4):847-851. PubMed ID: 34994375 [TBL] [Abstract][Full Text] [Related]
3. New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity. Guillon J; Moreau S; Mouray E; Sinou V; Forfar I; Fabre SB; Desplat V; Millet P; Parzy D; Jarry C; Grellier P Bioorg Med Chem; 2008 Oct; 16(20):9133-44. PubMed ID: 18819813 [TBL] [Abstract][Full Text] [Related]
4. One-pot synthesis of biologically active 1,2,3-trisubstituted pyrrolo[2,3-b]quinoxalines through a palladium-catalyzed reaction with internal alkyne moieties. Keivanloo A; Besharati-Seidani T; Kaboudin B; Yoshida A; Yokomatsu T Mol Divers; 2018 Nov; 22(4):879-891. PubMed ID: 29909566 [TBL] [Abstract][Full Text] [Related]
5. One-pot sequential coupling reactions as a new practical protocol for the synthesis of unsymmetrical 2,3-diethynyl quinoxalines and 4-ethynyl-substituted pyrrolo[1,2-a]quinoxalines. Keivanloo A; Lashkari S; Bakherad M; Fakharian M; Abbaspour S Mol Divers; 2021 May; 25(2):981-993. PubMed ID: 32301033 [TBL] [Abstract][Full Text] [Related]
6. Synthesis of 4-Aryl Pyrrolo[1,2-α]quinoxalines Ahn J; Lee SB; Song I; Chun S; Oh DC; Hong S J Org Chem; 2021 Jun; 86(11):7390-7402. PubMed ID: 34028267 [TBL] [Abstract][Full Text] [Related]
7. Palladium catalyzed synthesis and physical properties of indolo[2,3-b]quinoxalines. Hung TQ; Hoang do H; Thang NN; Dang TT; Ayub K; Villinger A; Friedrich A; Lochbrunner S; Flechsig GU; Langer P Org Biomol Chem; 2014 Aug; 12(32):6151-66. PubMed ID: 25001519 [TBL] [Abstract][Full Text] [Related]
8. Construction of Spirocyclic Pyrrolo[1,2- Liu H; Mai X; Xian J; Liu S; Zhang X; Li B; Chen X; Li Y; Xie F J Org Chem; 2022 Dec; 87(24):16449-16457. PubMed ID: 36455265 [TBL] [Abstract][Full Text] [Related]
9. NCS-promoted thiocyanation and selenocyanation of pyrrolo[1,2-a]quinoxalines. Yang Z; He J; Wei Y; Li W; Liu P; Zhao J; Wei Y Org Biomol Chem; 2020 Nov; 18(44):9088-9094. PubMed ID: 33146224 [TBL] [Abstract][Full Text] [Related]
10. A direct entry to polycyclic quinoxaline derivatives Samanta SK; Sarkar R; Sengupta U; Das S; Ganguly D; Hasija A; Chopra D; Bera MK Org Biomol Chem; 2022 Jun; 20(22):4650-4658. PubMed ID: 35612282 [TBL] [Abstract][Full Text] [Related]
11. TFAA-Catalyzed Annulation Synthesis of Spiro Pyrrolo[1,2-a]quinoxaline Derivatives from 1-(2-Aminophenyl)pyrroles and Benzoquinones/Ketones. Ni J; Jiang Y; Qi Z; Yan R Chem Asian J; 2019 Aug; 14(16):2898-2902. PubMed ID: 31283108 [TBL] [Abstract][Full Text] [Related]
12. FeCl An Z; Zhao L; Wu M; Ni J; Qi Z; Yu G; Yan R Chem Commun (Camb); 2017 Oct; 53(84):11572-11575. PubMed ID: 28990598 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines. Jonet A; Guillon J; Mullie C; Cohen A; Bentzinger G; Schneider J; Taudon N; Hutter S; Azas N; Moreau S; Savrimoutou S; Agnamey P; Dassonville-Klimpt A; Sonnet P Med Chem; 2018; 14(3):293-303. PubMed ID: 28745231 [TBL] [Abstract][Full Text] [Related]
14. Copper-catalyzed aerobic oxidative coupling of o-phenylenediamines with 2-aryl/heteroarylethylamines: direct access to construct quinoxalines. Gopalaiah K; Saini A; Chandrudu SN; Rao DC; Yadav H; Kumar B Org Biomol Chem; 2017 Mar; 15(10):2259-2268. PubMed ID: 28240337 [TBL] [Abstract][Full Text] [Related]
15. Iron-Catalyzed Intramolecular C(sp(2))-N Cyclization of 1-(N-Arylpyrrol-2-yl)ethanone O-Acetyl Oximes toward Pyrrolo[1,2-a]quinoxaline Derivatives. Zhang Z; Li J; Zhang G; Ma N; Liu Q; Liu T J Org Chem; 2015 Jul; 80(13):6875-84. PubMed ID: 26057737 [TBL] [Abstract][Full Text] [Related]
16. One-Pot Synthesis of Pyrrolo[1,2-a]quinoxaline Derivatives via a Copper-Catalyzed Aerobic Oxidative Domino Reaction. Liu H; Duan T; Zhang Z; Xie C; Ma C Org Lett; 2015 Jun; 17(12):2932-5. PubMed ID: 26052923 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III. Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of new 4-(E)-alkenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents by Suzuki-Miyaura cross-coupling reactions. Guillon J; Forfar I; Desplat V; Fabre SB; Thiolat D; Massip S; Carrie H; Mossalayi D; Jarry C J Enzyme Inhib Med Chem; 2007 Oct; 22(5):541-9. PubMed ID: 18035821 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of new 4-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]quinoxaline and 5-[2-(alkylamino) ethylthio]pyrrolo[1,2-a]thieno[3,2-e]pyrazine derivatives, as potential bacterial multidrug resistance pump inhibitors. Vidaillac C; Guillon J; Moreau S; Arpin C; Lagardère A; Larrouture S; Dallemagne P; Caignard DH; Quentin C; Jarry C J Enzyme Inhib Med Chem; 2007 Oct; 22(5):620-31. PubMed ID: 18035830 [TBL] [Abstract][Full Text] [Related]
20. Monodentate Transient Directing Group-Assisted Palladium-Catalyzed Direct La M; Liu D; Chen X; Zhang FL; Zhou Y Org Lett; 2021 Dec; 23(23):9184-9188. PubMed ID: 34787425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]